LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c

LeonaBio, Inc. (NASDAQ: LONA) reported Q2 EPS of ($0.80), $0.32 better than the analyst estimate of ($1.12).

For earnings history and earnings-related data on LeonaBio, Inc. (LONA) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• BofA Securities Reiterates Buy Rating on NVIDIA (NVDA)
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy